Prevalence and Incidence of Multiple endocrine neoplasia type 2
Prevalance of Multiple endocrine neoplasia type 2:
about 1 per 300 000 people suffer from multiple endocrine neoplasia type 1 in the US, Genetics Home Reference website ... see also overview of Multiple endocrine neoplasia type 2.
Prevalance Rate:
approx 1 in 300 or 0.33% or 906,666 people in USA [Source statistic for calcuation: "about 1 per 300 000 people suffer from multiple endocrine neoplasia type 1 in the US, Genetics Home Reference website" -- see also general information about data sources]
Multiple endocrine neoplasia type 2: Rare Disease
Multiple endocrine neoplasia type 2 is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Multiple endocrine neoplasia type 2, or a subtype of Multiple endocrine neoplasia type 2,
affects less than 200,000 people in the US population.
Ophanet, who are a consortium of European partners,
currently defines a condition rare when if affects 1 person per 2,000.
They list Multiple endocrine neoplasia type 2 as a "rare disease".
More information about Multiple endocrine neoplasia type 2 is available from Orphanet
Multiple endocrine neoplasia type 2 Prevalence: Book Excerpts
Prevalence/Incidence of Multiple endocrine neoplasia type 2: Online Medical Books
16 MEDICAL BOOKS ONLINE!
Review excerpts from medical books online, free, without registration,
for more information about the prevalence and/or incidence of Multiple endocrine neoplasia type 2.
Multiple endocrine neoplasia:
Causes and incidence
(Professional Guide to Diseases (Eighth Edition))
MEN usually results from autosomal dominant inheritance. It affects males twice as often as females and may occur at any time from adolescence to old age, but is rare in children.There’s no racial predilection.
» READ BOOK EXCERPT ONLINE »
Source: Professional Guide to Diseases (Eighth Edition), 2005
Pheochromocytoma:
Causes and incidence
(Professional Guide to Diseases (Eighth Edition))
A pheochromocytoma may result from an inherited autosomal dominant trait. According to some estimates, about 0.5% of newly diagnosed patients with hypertension have pheochromocytoma. While this tumor is usually benign, it may be malignant in as many as 10% of these patients. It affects all races and both sexes, occurring primarily between ages 30 and 40.
» READ BOOK EXCERPT ONLINE »
Source: Professional Guide to Diseases (Eighth Edition), 2005
About prevalence and incidence statistics:
The term 'prevalence' of Multiple endocrine neoplasia type 2 usually refers to the estimated population
of people who are managing Multiple endocrine neoplasia type 2 at any given time.
The term 'incidence' of Multiple endocrine neoplasia type 2 refers to the annual diagnosis rate,
or the number of new cases of Multiple endocrine neoplasia type 2 diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.
A diagnosis of breast cancer usually leads to some form of surgery. Afterward, various therapies help guard against spread or recurrence of disease....
While training for the Olympic games, track star Gail Devers began to suffer from a number of mysterious symptoms: weight loss, dry skin and fatigue....
That men and women have different bodies is news to no one. But with the advance of the medical sciences, more and more fascinating differences have...
Stress takes its toll by making us anxious, depressed and not able to function as fully as we'd like. What many don't know is that stress can...
See full list of 4 related videos
» Next page: Videos related to Multiple endocrine neoplasia type 2
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards:
